Home
Scholarly Works
The impact of impaired renal function on the...
Conference

The impact of impaired renal function on the effectiveness of first-line immuno-oncology combination therapies in metastatic renal cell carcinoma (mRCC): Results from the international metastatic RCC database consortium (IMDC)

Authors

Navani V; Ernst MS; Takemura K; Pal SK; Powles TB; Donskov F; Wells JC; Kollmannsberger CK; Beuselinck B; Alva AS

Volume

suppl 7

Pagination

pp. S660-S680

Publisher

Oxford University Press

Publication Date

September 10, 2022

Name of conference

ESMO Congress

Conference place

Paris, France

Conference start date

September 9, 2022

Conference end date

September 13, 2022

Conference proceedings

Annals of Oncology

Issue

33

ISSN

0923-7534

Contact the Experts team